Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice

Figure 2

The inhibition of tumor growth was enhanced by HemoHIM administration in melanoma-bearing mice which were injected with cisplatin. All mice performed as described in figure 3 were sacrificed at 17 days after initial injection of cisplatin. Tumor weight (A) and size (B) were measured. (C) Photographs of melanoma solid tumor taken from all mice of each group. There were twenty mice in each group. Data show the Mean ± SD. *p < 0.1 compared with only cisplatin treated group.

Back to article page